By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Sep 20, 2022/Video
Discover the latest insights and groundbreaking approaches that are shaping the present and future of pain management.
Jul 20, 2022/Members Only
Topics discussed: PHE update, Medicare Physician Fee Schedule, Home Health Rule, Commercial Payer Update.
Apr 19, 2024/Perspective
An exploration of the 2024 Medicare Advantage rule and CMS' push for more timely access to needed care.
Oct 26, 2022/Policies & Bylaws
House position: States APTA's support for unrestricted access to physical therapists as entry-point practitioners for activity participation, wellness, health, and disability determination.
We know the impact physical therapy can have on our patients, clients, and communities – but what about ourselves? APTA's Fit for Practice initiative is built to help PTs and PTAs grow and thrive, both personally and professionally. From career development to wellbeing, this initiative focuses on strategies
Nov 24, 2020/Article
The culturally competent practice of physical therapy includes practice with patients and clients who have mental or physical disabilities.
May 23, 2017/Test & Measure
Patients self rate the presence and severity of signs and symptoms such as blurred vision, dizziness, drowsiness, sleeping more than usual, easily distracted, fatigue, feeling “in a fog,” headache, and irritability.
Feb 13, 2025/Roundup
Resources to help guide your patient care are free to members and easy to find at apta.org. Here’s what was new in 2024.
Jun 9, 2025/Article
APTA is actively working with congressional leaders to address reports of remaining TRICARE payment and operational issues impacting physical therapy providers. These issues, which emerged at the start of 2025 when TriWest Healthcare Alliance took over as the Managed Care Support Contractor under the
Jan 13, 2023/Review
Authors found a dose-response relationship between PA and adverse COVID-19 events that was consistent across multiple subgroups.